Jasper P. Van Beek

Nijmegen, GE, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Pre-existing chromatin accessibility and gene expression differences among naive CD4+ T cells influence effector potential.

Pre-existing chromatin accessibility and gene expression differences among naive CD4+ T cells influence effector potential.

Journal: Cell reports

Published: July 06, 2021

Human type 1 and type 2 conventional dendritic cells express indoleamine 2,3-dioxygenase 1 with functional effects on T cell priming.

Human type 1 and type 2 conventional dendritic cells express indoleamine 2,3-dioxygenase 1 with functional effects on T cell priming.

Journal: European journal of immunology

Published: February 09, 2020

Human pDCs Are Superior to cDC2s in Attracting Cytolytic Lymphocytes in Melanoma Patients Receiving DC Vaccination.

Human pDCs Are Superior to cDC2s in Attracting Cytolytic Lymphocytes in Melanoma Patients Receiving DC Vaccination.

Journal: Cell reports

Published: August 27, 2019

Naturally produced type I IFNs enhance human myeloid dendritic cell maturation and IL-12p70 production and mediate elevated effector functions in innate and adaptive immune cells.

Naturally produced type I IFNs enhance human myeloid dendritic cell maturation and IL-12p70 production and mediate elevated effector functions in innate and adaptive immune cells.

Journal: Cancer immunology, immunotherapy : CII

Published: October 23, 2017

Human blood myeloid and plasmacytoid dendritic cells cross activate each other and synergize in inducing NK cell cytotoxicity.

Human blood myeloid and plasmacytoid dendritic cells cross activate each other and synergize in inducing NK cell cytotoxicity.

Journal: Oncoimmunology

Published: May 06, 2016

Innate Lymphoid Cells in Tumor Immunity.

Innate Lymphoid Cells in Tumor Immunity.

Journal: Biomedicines

Published: December 23, 2015

Dendritic cell cross talk with innate and innate-like effector cells in antitumor immunity: implications for DC vaccination.

Dendritic cell cross talk with innate and innate-like effector cells in antitumor immunity: implications for DC vaccination.

Journal: Critical reviews in immunology

Published: January 20, 2015

Protamine-stabilized RNA as an ex vivo stimulant of primary human dendritic cell subsets.

Protamine-stabilized RNA as an ex vivo stimulant of primary human dendritic cell subsets.

Journal: Cancer immunology, immunotherapy : CII

Published: October 31, 2014

Insight into mucinous colorectal carcinoma: clues from etiology.

Insight into mucinous colorectal carcinoma: clues from etiology.

Journal: Annals of surgical oncology

Published: March 03, 2014

Showing 1-9 of 9

Last Updated: 09/26/2026